The global SMA treatment market size was valued at US$ 4.40 billion in 2024 and is projected to reach US$ 13.09 billion by 2030, growing at a CAGR of 18.0% during the period 2025-2030.SMA is a rare genetic neuromuscular disorder characterised by progressive loss of motor neurons leading to muscle weakness and atrophy. Treatment options include gene replacement therapies, SMN-protein-modulating...